Positron Emission Tomography (PET) scanners are medical imaging devices that allow doctors to see cellular-level metabolic and functional processes in the body. A little amount of a radioactive substance, typically a radiotracer, is injected into the body, and it detects the release of pairs of gamma rays. This substance usually consists of a type of glucose or another positron-releasing decaying molecule.
According to SPER Market Research, ‘Global Positron Emission Tomography (PET) Scanner Market Size- By Modality, By Application, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Global Positron Emission Tomography (PET) Scanner Market is estimated to reach USD 3.87 billion by 2033 with a CAGR of 3.86%.
Drivers:
The growing demand for PET analysis in radiopharmaceuticals, the obvious move toward image-guided therapy, and developments in PET imaging technology for cancer and intricate diagnostic applications are some of the main causes. Implementing these advancements is anticipated to increase the use of PET scanners in a variety of medical specialties as the healthcare industry expands.
The market is expanding as a result of increased government funding for expediting drug development procedures while maintaining patient safety. The FDA’s Real-World Evidence (RWE) program, for example, encourages clinical studies to include real-world data, which can result in quicker approvals and more effective research designs.
Restraints:
The development of image-guided therapies, the growing need for PET analysis in radiopharmaceuticals, and improvements in PET imaging technology for cancer and complex diagnostic applications are some of the main factors. As the healthcare industry expands, it is anticipated that incorporating these advancements would increase the use of PET scanners across a variety of medical specializations.
Request a Free Sample Report: https://www.sperresearch.com/report-store/positron-emission-tomography-scanner-market.aspx?sample=1
The market is expanding as a result of growing government funding to expedite medication development procedures while maintaining patient safety. For example, the FDA’s Real-World Evidence (RWE) program encourages the inclusion of real-world data in clinical studies, which can result in faster approvals and more effective study designs.
Numerous constraints prevent the market for Positron Emission Tomography (PET) scanners from expanding and becoming extensively used. The high cost and maintenance needs of PET scanners are among the main obstacles preventing many healthcare facilities, particularly those in developing nations, from obtaining access to them. Because radiotracers are expensive and have a limited shelf life, it is challenging to administer and stock them appropriately for imaging. Additionally, the scanners themselves are expensive to buy. The logistical complexity is further increased by the requirement for specialized facilities to handle and construct these radiotracers.
Additionally, some of the market key players are Canon Medical Systems, GE Healthcare, Kindsway Biotech, Koninklijke Philips N.V., Mediso Ltd.
Positron Emission Tomography (PET) Scanner Market Segmentation:
By Modality: Based on the Modality, Global Positron Emission Tomography (PET) Scanner Market is segmented as; PET-CT, PET-MRI.
By Application: Based on the Application, Global Positron Emission Tomography (PET) Scanner Market is segmented as; Oncology, Cardiology, Neurology.
By End User: Based on the End User, Global Positron Emission Tomography (PET) Scanner Market is segmented as; Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes.
By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.
For More Information, refer to below link: –
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
+1-347-460-2899
